Prophylactic evaluation of Verubecestat on disease and symptom modifying effects in 5XFAD mice. Oblak AL, Cope ZA, Quinney SK, Pandey RS, Biesdorf C, Masters AR, Onos KD, Haynes L, Keezer KJ, Meyer JA, Peters JS, Persohn SA, Bedwell AA, Eldridge K, Speedy R, Little G, Williams S-P, Noarbe B, Obenaus A, Sasner M, Howell GR, Carter GW, Williams H, Lamb BT, Territo PR, Sukoff Rizzo SJ. Alzheimer’s & Dementia: Translational Research & Clinical Interventions. https://doi.org/10.1002/trc2.12317
Prophylactic evaluation of Verubecestat on disease and symptom modifying effects in 5XFAD mice
by abbottmj | Jul 14, 2022 | Uncategorized | 0 comments